Other Inflammatory Markers Should Not be Forgetten When Assessing the Neutrophil-to-Lymphocyte Ratio

Saved in:
Bibliographic Details
Published in:Clinical and applied thrombosis/hemostasis 2013-11, Vol.19 (6), p.693-694
Main Authors: Balta, Sevket, Demirkol, Sait, Cakar, Mustafa, Arslan, Zekeriya, Unlu, Murat, Celik, Turgay
Format: Article
Language:English
Subjects:
Biomarkers - blood
Disease Progression
Humans
Inflammation - blood
Lymphocyte Count
Lymphocytes - metabolism
Neutrophils - metabolism
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c407t-d0de6da1e14e90470feaeea408c681a57fd255fd35296e4a370dce79fe6691633
cites cdi_FETCH-LOGICAL-c407t-d0de6da1e14e90470feaeea408c681a57fd255fd35296e4a370dce79fe6691633
container_end_page 694
container_issue 6
container_start_page 693
container_title Clinical and applied thrombosis/hemostasis
container_volume 19
creator Balta, Sevket
Demirkol, Sait
Cakar, Mustafa
Arslan, Zekeriya
Unlu, Murat
Celik, Turgay
description
doi_str_mv 10.1177/1076029613486019
format article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_1459565025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1076029613486019</sage_id><sourcerecordid>2344187658</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-d0de6da1e14e90470feaeea408c681a57fd255fd35296e4a370dce79fe6691633</originalsourceid><addsrcrecordid>eNp1kctLxDAQxoMoPlbvniTgxUs1aV7NUcRVYXXBBx5LbKbbatusSXrY_97I-gDBy8zA95tvhhmEDik5pVSpM0qUJLmWlPFCEqo30C7VrMhylbPNVCc5-9R30F4IryQRUstttJMzSUWu2S6y89iAxzdD3Zm-N9H5Fb41_g18wA-NGzuL71zEL4Cnzi8gRhjwc5PCeQgQQjsscDLAdzBG75ZN22XRZbNVv2xctYqA701s3T7aqk0X4OArT9DT9PLx4jqbza9uLs5nWcWJipklFqQ1FCgHTbgiNRgAw0lRyYIaoWqbC1FbllaXwA1TxFagdA1SaioZm6CTte_Su_cRQiz7NlTQdWYAN4aScqGFFCQXCT3-g7660Q9puzJnnNNCSVEkiqypyrsQPNTl0re98auSkvLzA-XfD6SWoy_j8aUH-9PwffIEZGsgmAX8Tv3X8APl842T</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2344187658</pqid></control><display><type>article</type><title>Other Inflammatory Markers Should Not be Forgetten When Assessing the Neutrophil-to-Lymphocyte Ratio</title><source>SAGE Open Access</source><creator>Balta, Sevket ; Demirkol, Sait ; Cakar, Mustafa ; Arslan, Zekeriya ; Unlu, Murat ; Celik, Turgay</creator><creatorcontrib>Balta, Sevket ; Demirkol, Sait ; Cakar, Mustafa ; Arslan, Zekeriya ; Unlu, Murat ; Celik, Turgay</creatorcontrib><identifier>ISSN: 1076-0296</identifier><identifier>EISSN: 1938-2723</identifier><identifier>DOI: 10.1177/1076029613486019</identifier><identifier>PMID: 23615293</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Biomarkers - blood ; Disease Progression ; Humans ; Inflammation - blood ; Lymphocyte Count ; Lymphocytes - metabolism ; Neutrophils - metabolism ; Risk Factors</subject><ispartof>Clinical and applied thrombosis/hemostasis, 2013-11, Vol.19 (6), p.693-694</ispartof><rights>The Author(s) 2013</rights><rights>The Author(s) 2013. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at: https://uk.sagepub.com/en-gb/eur/reusing-open-access-and-sage-choice-content</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-d0de6da1e14e90470feaeea408c681a57fd255fd35296e4a370dce79fe6691633</citedby><cites>FETCH-LOGICAL-c407t-d0de6da1e14e90470feaeea408c681a57fd255fd35296e4a370dce79fe6691633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1076029613486019$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2344187658?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,21946,25732,27832,27903,27904,36991,36992,44569,44924,45312</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/1076029613486019?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23615293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balta, Sevket</creatorcontrib><creatorcontrib>Demirkol, Sait</creatorcontrib><creatorcontrib>Cakar, Mustafa</creatorcontrib><creatorcontrib>Arslan, Zekeriya</creatorcontrib><creatorcontrib>Unlu, Murat</creatorcontrib><creatorcontrib>Celik, Turgay</creatorcontrib><title>Other Inflammatory Markers Should Not be Forgetten When Assessing the Neutrophil-to-Lymphocyte Ratio</title><title>Clinical and applied thrombosis/hemostasis</title><addtitle>Clin Appl Thromb Hemost</addtitle><subject>Biomarkers - blood</subject><subject>Disease Progression</subject><subject>Humans</subject><subject>Inflammation - blood</subject><subject>Lymphocyte Count</subject><subject>Lymphocytes - metabolism</subject><subject>Neutrophils - metabolism</subject><subject>Risk Factors</subject><issn>1076-0296</issn><issn>1938-2723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNp1kctLxDAQxoMoPlbvniTgxUs1aV7NUcRVYXXBBx5LbKbbatusSXrY_97I-gDBy8zA95tvhhmEDik5pVSpM0qUJLmWlPFCEqo30C7VrMhylbPNVCc5-9R30F4IryQRUstttJMzSUWu2S6y89iAxzdD3Zm-N9H5Fb41_g18wA-NGzuL71zEL4Cnzi8gRhjwc5PCeQgQQjsscDLAdzBG75ZN22XRZbNVv2xctYqA701s3T7aqk0X4OArT9DT9PLx4jqbza9uLs5nWcWJipklFqQ1FCgHTbgiNRgAw0lRyYIaoWqbC1FbllaXwA1TxFagdA1SaioZm6CTte_Su_cRQiz7NlTQdWYAN4aScqGFFCQXCT3-g7660Q9puzJnnNNCSVEkiqypyrsQPNTl0re98auSkvLzA-XfD6SWoy_j8aUH-9PwffIEZGsgmAX8Tv3X8APl842T</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Balta, Sevket</creator><creator>Demirkol, Sait</creator><creator>Cakar, Mustafa</creator><creator>Arslan, Zekeriya</creator><creator>Unlu, Murat</creator><creator>Celik, Turgay</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>201311</creationdate><title>Other Inflammatory Markers Should Not be Forgetten When Assessing the Neutrophil-to-Lymphocyte Ratio</title><author>Balta, Sevket ; Demirkol, Sait ; Cakar, Mustafa ; Arslan, Zekeriya ; Unlu, Murat ; Celik, Turgay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-d0de6da1e14e90470feaeea408c681a57fd255fd35296e4a370dce79fe6691633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biomarkers - blood</topic><topic>Disease Progression</topic><topic>Humans</topic><topic>Inflammation - blood</topic><topic>Lymphocyte Count</topic><topic>Lymphocytes - metabolism</topic><topic>Neutrophils - metabolism</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balta, Sevket</creatorcontrib><creatorcontrib>Demirkol, Sait</creatorcontrib><creatorcontrib>Cakar, Mustafa</creatorcontrib><creatorcontrib>Arslan, Zekeriya</creatorcontrib><creatorcontrib>Unlu, Murat</creatorcontrib><creatorcontrib>Celik, Turgay</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and applied thrombosis/hemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Balta, Sevket</au><au>Demirkol, Sait</au><au>Cakar, Mustafa</au><au>Arslan, Zekeriya</au><au>Unlu, Murat</au><au>Celik, Turgay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Other Inflammatory Markers Should Not be Forgetten When Assessing the Neutrophil-to-Lymphocyte Ratio</atitle><jtitle>Clinical and applied thrombosis/hemostasis</jtitle><addtitle>Clin Appl Thromb Hemost</addtitle><date>2013-11</date><risdate>2013</risdate><volume>19</volume><issue>6</issue><spage>693</spage><epage>694</epage><pages>693-694</pages><issn>1076-0296</issn><eissn>1938-2723</eissn><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>23615293</pmid><doi>10.1177/1076029613486019</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 1076-0296
ispartof Clinical and applied thrombosis/hemostasis, 2013-11, Vol.19 (6), p.693-694
issn 1076-0296
1938-2723
language eng
recordid cdi_proquest_miscellaneous_1459565025
source SAGE Open Access
subjects Biomarkers - blood
Disease Progression
Humans
Inflammation - blood
Lymphocyte Count
Lymphocytes - metabolism
Neutrophils - metabolism
Risk Factors
title Other Inflammatory Markers Should Not be Forgetten When Assessing the Neutrophil-to-Lymphocyte Ratio
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A35%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Other%20Inflammatory%20Markers%20Should%20Not%20be%20Forgetten%20When%20Assessing%20the%20Neutrophil-to-Lymphocyte%20Ratio&rft.jtitle=Clinical%20and%20applied%20thrombosis/hemostasis&rft.au=Balta,%20Sevket&rft.date=2013-11&rft.volume=19&rft.issue=6&rft.spage=693&rft.epage=694&rft.pages=693-694&rft.issn=1076-0296&rft.eissn=1938-2723&rft_id=info:doi/10.1177/1076029613486019&rft_dat=%3Cproquest_AFRWT%3E2344187658%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c407t-d0de6da1e14e90470feaeea408c681a57fd255fd35296e4a370dce79fe6691633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2344187658&rft_id=info:pmid/23615293&rft_sage_id=10.1177_1076029613486019&rfr_iscdi=true